Comparative Effect of Quercetin and Quercetin-3-O-β-d-Glucoside on Fibrin Polymers, Blood Clots, and in Rodent Models

Journal of Biochemical and Molecular Toxicology

Volumn 30, Issue 11, 2016, Pages 548-558

  Choi, Jun Hui ^a   Kim, Kyung Je ^b   Kim, Seung ^a  

^a Kwangju University   (South Korea)

^b Jangheung research institute for mushroom industry   (South Korea)

Author keywords

Anticoagulation; Antithrombotic; Platelet Activation; Quercetin; Quercetin 3 O d Glucoside

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10; COLLAGEN; EPINEPHRINE; FIBRIN; FLAVONOID; HEPARIN; ISOQUERCETIN; POLYMER; QUERCETIN; THROMBIN; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR 10A; FIBRINOLYTIC AGENT; QUERCETIN 3'-O-GLUCOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; ASSAY; BLOOD CLOTTING; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; EX VIVO STUDY; FIBRIN CLOT; FLUORESCENCE MICROSCOPY; HEMOSTASIS; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOEMBOLISM; ACUTE DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; THROMBOCYTE;

ACUTE DISEASE; ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; COLLAGEN; DISEASE MODELS, ANIMAL; EPINEPHRINE; FACTOR XA; FIBRIN; FIBRINOLYTIC AGENTS; FLAVONOIDS; MALE; MICE; MICE, INBRED ICR; PLATELET ACTIVATION; PRIMARY CELL CULTURE; QUERCETIN; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; THROMBIN; THROMBOEMBOLISM;

EID: 84973582110     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21822     Document Type: Article

References (41)

1. Hopia A, Heinonen M. Antioxidant activity of flavonol aglycones and their glycosides in methyl linoleate. J Am Oil Chem Soc 1999;76:139–144.
2. Pietta PG. Flavonoids as antioxidants. J Nat Prod 2000;63:1035–1042.
3. Maeda J, Roybal EJ, Brents CA, Uesaka M, Aizawa Y, Kato TA. Natural and glucosyl flavonoids inhibit poly (ADP-ribose) polymerase activity and induce synthetic lethality in BRCA mutant cells. Oncol Rep 2014;31:551–556.
4. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002;22:19–34.
5. Kumar S, Abhay KP. Chemistry and biological activities of flavonoids: an overview. Sci World J 2013;2013:162750.
6. Perez-Vizcaino F, Duarte J. Flavonols and cardiovascular disease. Mol Asp Med 2010;31:478–494.
7. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the zutphen elderly study. Lancet 1993;342:1007–1011.
8. Middleton Jr E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52:673–751.
9. Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, Lines TC. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 2007;45:2179–2205
10. Magalingam KB, Radhakrishnan A, Haleagrahara N. Protective effects of flavonol isoquercitrin, against 6-hydroxy dopamine (6-OHDA)-induced toxicity in PC12 cells. BMC Res Notes 2014;7:49.
11. United States Department of Agriculture. 1994–1996, 1998 Continuing survey of food intakes by individuals and diet and health knowledge survey. US Dept of Agriculture, Riverdale, Maryland 2000.
12. Ruiz MJ, Fernández M, Picó Y, Mañes J, Asensi M, Carda C, Asensio G, Estrela JM. Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. J Agric Food Chem 2009;57:3180–3186.
13. Sim GS, Lee BC, Cho HS, Lee JW, Kim JH, Lee DH, Kim JH, Pyo HB, Moon DC, Oh KW, Yun YP, Hong JT. Structure activity relationship of antioxidative property of flavonoids and inhibitory effect on matrix metalloproteinase activity in UVA-irradiated human dermal fibroblast. Arch Pharm Res 2007;30:290–298.
14. Chaillou LL, Nazareno MA. New method to determine antioxidant activity of polyphenols. J Agric Food Chem 2006;54:8397–8402.
15. Alcocer F, Whitley D, Salazar Gonzales JF, Jordan WD, Sellers MT, Eckhoff DE, Suzuki K, Macrae C, Bland KI. Quercetin inhibits human vascular smooth muscle cell proliferation and migration. Surgery 2002;131:198–204.
16. Moon SK, Cho GO, Jung SY, Gal SW, Kwon TK, Lee YC, Madamanchi NR, Kim CH. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun 2003;301:1069–1078.
17. Galisteo M, García-Saura MF, Jiménez R, Villar IC, Zarzuelo A, Vargas F, Duarte J. Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salthypertensive rats. Mol Cell Biochem 2004;259:91–99.
18. Garcia-Saura MF, Galisteo M, Villar IC, Bermejo A, Zarzuelo A, Vargas F, Duarte J. Effects of chronic quercetin treatment in experimental renovascular hypertension. Mol Cell Biochem 2005;270:147–155.
19. Cui J, Cordis GA, Tosaki A, Maulik N, Das DK. Reduction of myocardial ischemia reperfusion injury with regular consumption of grapes. Ann NY Acad Sci 2002;957:302–307.
20. Kimata M, Shichijo M, Miura T, Serizawa I, Inagaki N, Nagai H. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy 2000;30:501–508.
21. Mosawy S, Jackson DE, Woodman OL, Linden MD. Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3′, 4′-dihydroxyflavonol and quercetin. Platelets 2013;24:594–604.
22. Mosawy S, Jackson DE, Woodman OL, Linden MD. Treatment with quercetin and 3′,4′-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo. J Thromb Thrombolysis 2013;36:50–57.
23. Mosawy S, Jackson DE, Woodman OL, Linden MD. The flavonols quercetin and 3′,4′-dihydroxyflavonol reduce platelet function and delay thrombus formation in a model of type 1 diabetes. Diab Vasc Dis Res 2014;11:174–181.
24. Kaneider NC, Mosheimer B, Reinisch N, Patsch JR, Wiedermann CJ. Inhibition of thrombin-induced signaling by resveratrol and quercetin: effects on adenosine nucleotide metabolism in endothelial cells and platelet-neutrophil interactions. Thromb Res 2004;114:185–194.
25. Lee KH, Park E, Lee HJ, Kim MO, Cha YJ, Kim JM, Lee H, Shin MJ. Effects of daily quercetin-rich supplementation on cardiometabolic risks in male smokers. Nutr ResPract 2011;5:28–33.
26. Egert S, Boesch-Saadatmandi C, Wolffram S, Rimbach G, Müller MJ. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J Nutr 2010;140:278–284.
27. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J Nutr 2007;137:2405–2411.
28. Pfeuffer M, Auinger A, Bley U, Kraus-Stojanowic I, Laue C, Winkler P, Rüfer CE, Frank J, Bösch-Saadatmandi C, Rimbach G, Schrezenmeir J. Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammatory parameters in men with different APOE isoforms. Nutr Metab CardiovascDis 2011;23;403–409.
29. Guo C, Liu S, Guo Y, Yin Y, Lin J, Chen X, Sun MZ. Comparative function-structural analysis of antiplatelet and antiradical activities of flavonoid phytochemicals. J Anim Plant Sci 2014;24:926–935.
30. National Institutes of Health. NIH Guide for the Care and Use of Laboratory Animals. Bethesda. MD: NIH Publication; revised 1996. No. 80–23.
31. Choi JH, Park SE, Kim SJ, Kim S. Kaempferol inhibits thrombosis and platelet activation. Biochimie 2015;115:177–186.
32. Gaspar AR, Crause JC, Neitz AW. Identification of anticoagulant activities in the salivary glands of the soft tick, Ornithodoros savignyi. Exp Appl Acarol 1995;19:117–127.
33. Broersma RJ, Kutcher LW, Heminger EF, Krstenansky JL, Marshall FN. Antithrombotic activity of a novel C-terminal hirudin analog in experimental animals. Thromb Haemost 1991;65:377–381.
34. Gomi K, Zushi M, Honda G, Kawahara S, Matsuzaki O, Kanabayashi T, Yamamoto S, Maruyama I, Suzuki K. Antithrombotic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice. Blood 1990;75:1396–1399.
35. Wang X, Cheng Q, Xu L, Feuerstein GZ, Hsu MY, Smith PL, Seiffert DA, Schumacher WA, Ogletree ML, Gailani DJ. Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice. Thromb Haemost 2005;3:695–702.
36. Kondo H, Kondo S, Ikezawa H, Murata R. Studies on the quantitative method for determination of hemorrhagic activity of Habu snake venom. Jpn J Med Sci Biol 1960;13:43–52.
37. Khoo NK, White CR, Pozzo-Miller L, Zhou F, Constance C, Inoue T, Patel RP, Parks DA. Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels. Free Radic Biol Med 2010;49:339–347.
38. Rao AS, Reddy SG, Babu PP. The antioxidant and antiproliferative activities of methanolic extracts from Njavara rice bran. BMC Complement Altern Med 2010;10:1–9.
39. Liu L, Ma H, Yang N, Tang Y, Guo J, Tao W, Duan J. A series of natural flavonoids as thrombin inhibitors: structure-activity relationships. Thromb Res 2010;126:e365–e378.
40. Voet D, Voet JG. Biochemistry. New York: John Wiley; 1990, pp 1087–1095.
41. Henry BL, Monien BH, Bock PE, Desai UR. A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids. J Biological Chem 2007;282:31891–31899.